Condition: Chronic Cluster Headache
Interventions: Drug: Fremanezumab- A; Drug: Fremanezumab- B; Drug: Placebo
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified July 2017
Source: ClinicalTrials.gov Listing of Cluster Headache trials
The purpose of the current study is to evaluate the efficacy and safety of TEV-48125 (Fremanezumab), in the prevention of CCH in adult patients.
2016-11-11